Physician

Michael A Jenkins, MD

According to 2025 Medicare claims, Michael Jenkins, MD (NPI: 1790771277) practices urology in the Panama City-Panama City Beach, FL market, with the plurality of this provider's patient population coming from Bay, FL. This provider's primary affiliated billing organization is ADVANCED UROLOGY INSTITUTE, LLC (NPI: 1023447935; TIN: 46-2439971) and primary practice location at 32401-6304.

Jenkins' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,134 traditional Medicare patients, billed 26,684 HCPCS/CPT codes, and received $488,293 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,363 prescription claims across 487 beneficiaries totaling $471,265 in drug costs, led by Xtandi (Enzalutamide). DME data shows 41 claims. Open Payments data shows 29 records totaling $955. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $76,323 to $471,265. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $483 to $1,077.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,112	17,474	$425,591
2016	1,189	16,840	$455,477
2017	1,011	17,440	$476,502
2018	1,006	14,661	$377,970
2019	1,168	22,769	$402,196
2020	1,214	31,220	$463,811
2021	1,202	19,386	$462,388
2022	1,093	19,464	$433,346
2023	1,035	22,957	$403,445
2024	1,134	26,684	$488,293

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	321	958	$76,323
2016	323	1,199	$245,305
2017	356	1,098	$99,225
2018	339	1,091	$105,716
2019	371	1,206	$96,350
2020	372	1,157	$103,498
2021	363	1,028	$124,553
2022	380	1,026	$130,607
2023	442	1,273	$431,501
2024	487	1,363	$471,265

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	34	109	$17,718
2016	31	158	$8,805
2017	N/R	17	$3,515
2018	N/R	49	$8,935
2019	N/R	102	$46,944
2020	N/R	120	$57,198
2021	N/R	54	$33,312
2022	N/R	63	$29,944
2023	N/R	111	$40,089
2024	N/R	41	$25,837

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	427	654	$95
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	438	622	$68
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	527	781	$12
36415	Insertion of needle into vein for collection of blood sample	319	361	$7
81003	Automated urinalysis test	655	1,098	$2

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xtandi	Enzalutamide	25	750	$369,314
Myrbetriq	Mirabegron	72	3,187	$47,870
Gemtesa	Vibegron	21	891	$14,238
Testosterone	Testosterone	25	1,360	$7,096
Testosterone Cypionate	Testosterone Cypionate	94	6,450	$4,622

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4352	Intermittent urinary catheter; coude (curved) tip, with or without coating (teflon, silicone, silicone elastomeric, or hydrophilic, etc.), each	N	N/R	16	$17,718
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	N/R	25	$8,119

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	29	$955	PROCEPT BioRobotics Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Michael A. Jenkins, MD?

Tedicare shows public-source Medicare data for Michael A. Jenkins, MD (NPI 1790771277), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael A. Jenkins, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Michael A. Jenkins, MD?

Michael A. Jenkins, MD is linked to ADVANCED UROLOGY INSTITUTE, LLC (billing NPI 1023447935) in the available physician profile data.

Does Michael A. Jenkins, MD have Open Payments data?

Michael A. Jenkins, MD has 29 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.